Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2020 | CheckMate 214 trial update

Laurence Albiges • 18 Sep 2020
ESMO 2020
Kidney Cancer Ipilimumab Nivolumab Sunitinib
CheckMate 214

Laurence Albiges, MD, PhD, Gustave Roussy Institute, Villejuif, France, discusses the CheckMate 214 clinical trial (NCT02231749), involving nivolumab + ipilimumab vs sunitinib for first-line treatment of advanced renal cell carcinoma (aRCC), in a 4-year follow-up and subgroup analysis of patients without nephrectomy. After 4 years follow-up, overall survival (OS) and objective response rate (ORR) benefits were maintained with nivolumab + ipilimumab vs sunitinib. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Laurence Albiges

LITESPARK-005: Belzutifan versus everolimus in ccRCC
2:48
LITESPARK-005: Belzutifan versus everolimus in ccRCC
Laurence Albiges • 21 Oct 2023
Biomarker development in RCC and UC
4:21
Biomarker development in RCC and UC
Laurence Albiges • 23 Sep 2021
Current and emerging treatment strategies for patients with mccRCC
2:24
Current and emerging treatment strategies for patients with mccRCC
Laurence Albiges • 23 Sep 2021
BIONIKK: the first trial study in mccRCC
1:50
BIONIKK: the first trial study in mccRCC
Laurence Albiges • 18 Sep 2020

Related Videos

How has SABR improved radiotherapy practice in kidney cancer?
1:06
How has SABR improved radiotherapy practice in kidney cancer?
Shankar Siva • 16 May 2026
Which patients with kidney cancer may benefit from SABR treatment?
1:58
Which patients with kidney cancer may benefit from SABR treatment?
Shankar Siva • 16 May 2026
Emotional health burden and unmet support needs in kidney cancer
2:19
Emotional health burden and unmet support needs in kidney cancer
Eric Jonasch • 30 May 2026
Improving emotional health assessment in patients with kidney cancer
0:57
Improving emotional health assessment in patients with kidney cancer
Eric Jonasch • 30 May 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals